-
Eliglustat, sold
under the
brand name Cerdelga, is a
medication used for the
treatment of Gaucher's disease. It was
discovered at the
University of Michigan...
- It is
classified under EC 2.4.1.80. It is
inhibited by
miglustat and
eliglustat, both
drugs developed for the
treatment of
Gaucher disease.[citation needed]...
- harm in Gaucher's. This
approach is
called substrate reduction therapy.
Eliglustat (Cerdelga) (approved in 2014) is also a
small molecule. The
compound is...
-
Carticel (Knee
cartilage replacement therapy), for knee pain.
Cerdelga (
Eliglustat), for type 1
gaucher disease.
Ceredase (Alglucerase), for Gaucher's disease...
- 2000. In 2014
eliglustat tartrate was
approved by the Food and Drug
Administration and the
European Medicines ****ociation.
Eliglustat tartrate was the...
-
Norman S.
Radin was a
neurochemist who,
along with Jim Shayman,
developed eliglustat, a drug for
treating Gaucher's disease. Born in New York City, he received...
-
elgodipine (INN)
Elidel Eligard (Sanofi-Aventis)
redirects to
leuprorelin eliglustat (USAN)
Elimite elinafide (INN)
elinogrel (USAN, INN)
eliprodil (INN) elisartan...
-
Sapropterin A16AX08
Teduglutide A16AX09
Glycerol phenylbutyrate A16AX10
Eliglustat A16AX11
Sodium benzoate A16AX12
Trientine A16AX13
Uridine triacetate A16AX14...
- the
treatment of Gaucher's
disease A****ostat (development terminated)
Eliglustat Miglustat Velaglucerase alfa
taliglucerase alfa "Cerezyme EPAR". European...
- the
treatment of Gaucher's
disease with a
different mechanism of
action Eliglustat Dulsat C,
Mealy N (2009). "Iso****omine tartrate".
Drugs of the ****ure...
